Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, 323 00 Pilsen, Czech Republic.
Int J Mol Sci. 2020 Apr 2;21(7):2473. doi: 10.3390/ijms21072473.
Oxidative stress with subsequent premutagenic oxidative DNA damage has been implicated in colorectal carcinogenesis. The repair of oxidative DNA damage is initiated by lesion-specific DNA glycosylases (hOGG1, NTH1, MUTYH). The direct evidence of the role of oxidative DNA damage and its repair is proven by hereditary syndromes (MUTYH-associated polyposis, NTHL1-associated tumor syndrome), where germline mutations cause loss-of-function in glycosylases of base excision repair, thus enabling the accumulation of oxidative DNA damage and leading to the adenoma-colorectal cancer transition. Unrepaired oxidative DNA damage often results in G:C>T:A mutations in tumor suppressor genes and proto-oncogenes and widespread occurrence of chromosomal copy-neutral loss of heterozygosity. However, the situation is more complicated in complex and heterogeneous disease, such as sporadic colorectal cancer. Here we summarized our current knowledge of the role of oxidative DNA damage and its repair on the onset, prognosis and treatment of sporadic colorectal cancer. Molecular and histological tumor heterogeneity was considered. Our study has also suggested an additional important source of oxidative DNA damage due to intestinal dysbiosis. The roles of base excision repair glycosylases (hOGG1, MUTYH) in tumor and adjacent mucosa tissues of colorectal cancer patients, particularly in the interplay with other factors (especially microenvironment), deserve further attention. Base excision repair characteristics determined in colorectal cancer tissues reflect, rather, a disease prognosis. Finally, we discuss the role of DNA repair in the treatment of colon cancer, since acquired or inherited defects in DNA repair pathways can be effectively used in therapy.
氧化应激会导致前诱变氧化 DNA 损伤,从而导致结直肠癌的发生。氧化 DNA 损伤的修复是由损伤特异性 DNA 糖苷酶(hOGG1、NTH1、MUTYH)启动的。遗传综合征(MUTYH 相关息肉病、NTHL1 相关肿瘤综合征)为氧化 DNA 损伤及其修复作用提供了直接证据,这些综合征的种系突变导致碱基切除修复糖苷酶的功能丧失,从而使氧化 DNA 损伤积累,并导致腺瘤-结直肠癌转化。未修复的氧化 DNA 损伤常导致肿瘤抑制基因和原癌基因中的 G:C>T:A 突变,以及广泛发生的染色体拷贝中性杂合性丢失。然而,在复杂和异质性疾病(如散发性结直肠癌)中,情况更为复杂。在这里,我们总结了目前关于氧化 DNA 损伤及其修复在散发性结直肠癌发病、预后和治疗中的作用的知识。考虑了分子和组织学肿瘤异质性。我们的研究还提示了由于肠道菌群失调导致的氧化 DNA 损伤的另一个重要来源。碱基切除修复糖苷酶(hOGG1、MUTYH)在结直肠癌患者肿瘤和相邻黏膜组织中的作用,特别是与其他因素(尤其是微环境)的相互作用,值得进一步关注。在结直肠癌组织中确定的碱基切除修复特征反映的是疾病预后。最后,我们讨论了 DNA 修复在结肠癌治疗中的作用,因为 DNA 修复途径的获得性或遗传性缺陷可以有效地用于治疗。